A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 7,600 shares of SRRK stock, worth $225,188. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,600
Previous 5,500 38.18%
Holding current value
$225,188
Previous $97,000 35.05%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.84 - $16.79 $4.17 Million - $8.93 Million
-531,793 Reduced 82.48%
112,996 $941,000
Q1 2024

May 15, 2024

BUY
$13.2 - $17.76 $1.4 Million - $1.88 Million
105,939 Added 19.66%
644,789 $11.5 Million
Q4 2023

Feb 14, 2024

BUY
$6.52 - $20.32 $3.22 Million - $10 Million
493,130 Added 1078.59%
538,850 $10.1 Million
Q3 2023

Nov 14, 2023

BUY
$6.02 - $7.76 $275,234 - $354,787
45,720 New
45,720 $324,000
Q1 2023

May 15, 2023

SELL
$7.36 - $12.72 $59,093 - $102,128
-8,029 Reduced 6.91%
108,134 $865,000
Q4 2022

Feb 14, 2023

SELL
$7.02 - $9.76 $1.31 Million - $1.82 Million
-186,963 Reduced 61.68%
116,163 $1.05 Million
Q3 2022

Nov 14, 2022

BUY
$5.33 - $11.3 $443,770 - $940,826
83,259 Added 37.87%
303,126 $2.1 Million
Q2 2022

Aug 15, 2022

SELL
$4.66 - $13.96 $17,922 - $53,690
-3,846 Reduced 1.72%
219,867 $1.21 Million
Q1 2022

May 16, 2022

BUY
$11.89 - $24.68 $1.69 Million - $3.51 Million
142,143 Added 174.26%
223,713 $2.88 Million
Q3 2021

Nov 15, 2021

SELL
$27.38 - $42.21 $1.89 Million - $2.91 Million
-69,011 Reduced 45.83%
81,570 $2.69 Million
Q2 2021

Aug 16, 2021

BUY
$26.34 - $46.62 $2.68 Million - $4.74 Million
101,706 Added 208.09%
150,581 $4.35 Million
Q1 2021

May 17, 2021

SELL
$45.96 - $68.02 $4.07 Million - $6.03 Million
-88,591 Reduced 64.45%
48,875 $2.48 Million
Q4 2020

Feb 16, 2021

BUY
$13.72 - $51.57 $738,945 - $2.78 Million
53,859 Added 64.42%
137,466 $6.67 Million
Q3 2020

Nov 16, 2020

BUY
$10.54 - $18.47 $393,542 - $689,632
37,338 Added 80.7%
83,607 $1.48 Million
Q2 2020

Aug 14, 2020

BUY
$10.37 - $20.64 $315,559 - $628,075
30,430 Added 192.12%
46,269 $842,000
Q1 2020

May 15, 2020

SELL
$9.63 - $17.14 $180,745 - $321,700
-18,769 Reduced 54.23%
15,839 $192,000
Q4 2019

Feb 14, 2020

BUY
$7.2 - $13.2 $11,973 - $21,951
1,663 Added 5.05%
34,608 $456,000
Q3 2019

Nov 14, 2019

BUY
$8.95 - $15.72 $80,639 - $141,637
9,010 Added 37.64%
32,945 $294,000
Q2 2019

Aug 14, 2019

BUY
$14.61 - $22.45 $349,690 - $537,340
23,935 New
23,935 $380,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $1.53B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.